FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2575492746> ?p ?o ?g. }

• W2575492746 abstract "While tumor markers (carbohydrate antigen 19-9 [CA 19-9] and carcinoembryonic antigen [CEA]) can aid in the diagnosis of biliary tract cancer, their prognostic role has not been clearly elucidated. Therefore, this study was conducted to evaluate the prognostic role of tumor markers and tumor marker change in patients with advanced biliary tract cancer.Patients with pathologically proven metastatic or relapsed biliary tract cancer who were treated in a phase II trial of first-line S-1 and cisplatin chemotherapy were enrolled. Serum tumor markers were measured at baseline and after the first cycle of chemotherapy.Among a total of 104 patients, 80 (77%) had elevated baseline tumor markers (69 with CA 19-9 elevation and 40 with CEA). A decline ≥ 30% of the elevated tumor marker level after the first cycle of chemotherapy conferred an improved time to progression (TTP), overall survival (OS), and better chemotherapy response. Multivariate analysis revealed tumor marker decline as an independent positive prognostic factor of TTP (adjusted hazard ratio [HR], 0.44; p=0.003) and OS (adjusted HR, 0.37; p < 0.001). Subgroup analysis revealed similar results in each group of patients with CA 19-9 elevation and CEA elevation. In addition, elevated baseline CEA was associated with poor survival in both univariate and multivariate analysis.Tumor marker decline was associated with improved survival in biliary tract cancer. Measuring tumor marker after the first cycle of chemotherapy can be used as an early assessment of treatment outcome." @default.
• W2575492746 created "2017-01-26" @default.
• W2575492746 creator A5012153148 @default.
• W2575492746 creator A5019220210 @default.
• W2575492746 creator A5021490853 @default.
• W2575492746 creator A5044075250 @default.
• W2575492746 creator A5052823826 @default.
• W2575492746 creator A5053123311 @default.
• W2575492746 creator A5059766169 @default.
• W2575492746 creator A5063462114 @default.
• W2575492746 creator A5069050806 @default.
• W2575492746 creator A5071276908 @default.
• W2575492746 creator A5072696954 @default.
• W2575492746 creator A5078338048 @default.
• W2575492746 creator A5084687090 @default.
• W2575492746 creator A5089083236 @default.
• W2575492746 date "2017-07-15" @default.
• W2575492746 modified "2023-10-16" @default.
• W2575492746 title "CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy" @default.
• W2575492746 cites W1617009213 @default.
• W2575492746 cites W1825978543 @default.
• W2575492746 cites W1972046475 @default.
• W2575492746 cites W1996484986 @default.
• W2575492746 cites W2013099235 @default.
• W2575492746 cites W2019607817 @default.
• W2575492746 cites W2025769688 @default.
• W2575492746 cites W2075957912 @default.
• W2575492746 cites W2083042563 @default.
• W2575492746 cites W2087669041 @default.
• W2575492746 cites W2089112012 @default.
• W2575492746 cites W2104487249 @default.
• W2575492746 cites W2115261608 @default.
• W2575492746 cites W2128889451 @default.
• W2575492746 cites W2129563967 @default.
• W2575492746 cites W2139947970 @default.
• W2575492746 cites W2144692208 @default.
• W2575492746 cites W2149422956 @default.
• W2575492746 cites W2154711900 @default.
• W2575492746 cites W2158939683 @default.
• W2575492746 cites W2161817637 @default.
• W2575492746 cites W2169285224 @default.
• W2575492746 cites W344510317 @default.
• W2575492746 doi "https://doi.org/10.4143/crt.2016.326" @default.
• W2575492746 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5512384" @default.
• W2575492746 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28111425" @default.
• W2575492746 hasPublicationYear "2017" @default.
• W2575492746 type Work @default.
• W2575492746 sameAs 2575492746 @default.
• W2575492746 citedByCount "6" @default.
• W2575492746 countsByYear W25754927462017 @default.
• W2575492746 countsByYear W25754927462019 @default.
• W2575492746 countsByYear W25754927462020 @default.
• W2575492746 countsByYear W25754927462021 @default.
• W2575492746 crossrefType "journal-article" @default.
• W2575492746 hasAuthorship W2575492746A5012153148 @default.
• W2575492746 hasAuthorship W2575492746A5019220210 @default.
• W2575492746 hasAuthorship W2575492746A5021490853 @default.
• W2575492746 hasAuthorship W2575492746A5044075250 @default.
• W2575492746 hasAuthorship W2575492746A5052823826 @default.
• W2575492746 hasAuthorship W2575492746A5053123311 @default.
• W2575492746 hasAuthorship W2575492746A5059766169 @default.
• W2575492746 hasAuthorship W2575492746A5063462114 @default.
• W2575492746 hasAuthorship W2575492746A5069050806 @default.
• W2575492746 hasAuthorship W2575492746A5071276908 @default.
• W2575492746 hasAuthorship W2575492746A5072696954 @default.
• W2575492746 hasAuthorship W2575492746A5078338048 @default.
• W2575492746 hasAuthorship W2575492746A5084687090 @default.
• W2575492746 hasAuthorship W2575492746A5089083236 @default.
• W2575492746 hasBestOaLocation W25754927461 @default.
• W2575492746 hasConcept C121608353 @default.
• W2575492746 hasConcept C126322002 @default.
• W2575492746 hasConcept C143998085 @default.
• W2575492746 hasConcept C144301174 @default.
• W2575492746 hasConcept C144369459 @default.
• W2575492746 hasConcept C207103383 @default.
• W2575492746 hasConcept C2776694085 @default.
• W2575492746 hasConcept C2777387746 @default.
• W2575492746 hasConcept C2778239845 @default.
• W2575492746 hasConcept C2780210213 @default.
• W2575492746 hasConcept C2781447364 @default.
• W2575492746 hasConcept C38180746 @default.
• W2575492746 hasConcept C44249647 @default.
• W2575492746 hasConcept C71924100 @default.
• W2575492746 hasConcept C90924648 @default.
• W2575492746 hasConceptScore W2575492746C121608353 @default.
• W2575492746 hasConceptScore W2575492746C126322002 @default.
• W2575492746 hasConceptScore W2575492746C143998085 @default.
• W2575492746 hasConceptScore W2575492746C144301174 @default.
• W2575492746 hasConceptScore W2575492746C144369459 @default.
• W2575492746 hasConceptScore W2575492746C207103383 @default.
• W2575492746 hasConceptScore W2575492746C2776694085 @default.
• W2575492746 hasConceptScore W2575492746C2777387746 @default.
• W2575492746 hasConceptScore W2575492746C2778239845 @default.
• W2575492746 hasConceptScore W2575492746C2780210213 @default.
• W2575492746 hasConceptScore W2575492746C2781447364 @default.
• W2575492746 hasConceptScore W2575492746C38180746 @default.
• W2575492746 hasConceptScore W2575492746C44249647 @default.
• W2575492746 hasConceptScore W2575492746C71924100 @default.
• W2575492746 hasConceptScore W2575492746C90924648 @default.
• W2575492746 hasFunder F4320322034 @default.

• next